Search alternatives:
significantly advanced » significantly enhanced (Expand Search), significantly enhance (Expand Search), significantly enhances (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
advanced decrease » advanced disease (Expand Search), advanced defense (Expand Search), advanced breast (Expand Search)
significantly advanced » significantly enhanced (Expand Search), significantly enhance (Expand Search), significantly enhances (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
advanced decrease » advanced disease (Expand Search), advanced defense (Expand Search), advanced breast (Expand Search)
-
2141
Computational Fluid Dynamics results for a parallel plate flow chamber based on FLUENT.
Published 2025Subjects: -
2142
-
2143
-
2144
-
2145
Verification of PLUS CYCLE<sup>®</sup> signals during presumed sleep periods.
Published 2025Subjects: -
2146
-
2147
-
2148
Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models.
Published 2025Subjects: -
2149
-
2150
The characteristics of patient groups were used to prove the method’s applicability.
Published 2025Subjects: -
2151
-
2152
-
2153
-
2154
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
2155
-
2156
-
2157
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
2158
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
2159
-
2160